These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 25732554)
61. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin. Shi H; Cheng Q; Yuan S; Ding X; Liu Y Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808 [TBL] [Abstract][Full Text] [Related]
62. Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin. Webb MI; Walsby CJ Dalton Trans; 2011 Feb; 40(6):1322-31. PubMed ID: 21210063 [TBL] [Abstract][Full Text] [Related]
63. Exploring the interaction between picoplatin and human serum albumin: The effects on protein structure and activity. Wang Y; Wu P; Zhou X; Zhang H; Qiu L; Cao J J Photochem Photobiol B; 2016 Sep; 162():611-618. PubMed ID: 27484966 [TBL] [Abstract][Full Text] [Related]
64. Review: modifications of human serum albumin and their binding effect. Lee P; Wu X Curr Pharm Des; 2015; 21(14):1862-5. PubMed ID: 25732553 [TBL] [Abstract][Full Text] [Related]
65. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy. Babak MV; Ang WH Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025 [TBL] [Abstract][Full Text] [Related]
66. Characterization and side effect analysis of a newly designed nanoemulsion targeting human serum albumin for drug delivery. Divsalar A; Saboury AA; Nabiuni M; Zare Z; Kefayati ME; Seyedarabi A Colloids Surf B Biointerfaces; 2012 Oct; 98():80-4. PubMed ID: 22659208 [TBL] [Abstract][Full Text] [Related]
67. Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin. Zhang Y; Zhang Z; Gou Y; Jiang M; Khan H; Zhou Z; Liang H; Yang F J Inorg Biochem; 2017 Jul; 172():1-8. PubMed ID: 28395195 [TBL] [Abstract][Full Text] [Related]
68. Molecular structure-affinity relationship of bufadienolides and human serum albumin in vitro and molecular docking analysis. Zhou J; Lu G; Wang H; Zhang J; Duan J; Ma H; Wu Q PLoS One; 2015; 10(5):e0126669. PubMed ID: 25946161 [TBL] [Abstract][Full Text] [Related]
69. Comparative study on the interaction of two binuclear Pt (II) complexes with human serum albumin: Spectroscopic and docking simulation assessments. Shahsavani MB; Ahmadi S; Aseman MD; Nabavizadeh SM; Alavianmehr MM; Yousefi R J Photochem Photobiol B; 2016 Nov; 164():323-334. PubMed ID: 27723490 [TBL] [Abstract][Full Text] [Related]
70. Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma. Groessl M; Hartinger CG; Polec-Pawlak K; Jarosz M; Keppler BK Electrophoresis; 2008 May; 29(10):2224-32. PubMed ID: 18512673 [TBL] [Abstract][Full Text] [Related]
71. Study of curcumin and genistein interactions with human serum albumin. Mandeville JS; Froehlich E; Tajmir-Riahi HA J Pharm Biomed Anal; 2009 Feb; 49(2):468-74. PubMed ID: 19135819 [TBL] [Abstract][Full Text] [Related]
72. Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis. Aleksenko SS; Hartinger CG; Semenova O; Meelich K; Timerbaev AR; Keppler BK J Chromatogr A; 2007 Jul; 1155(2):218-21. PubMed ID: 17240384 [TBL] [Abstract][Full Text] [Related]
73. Separate and simultaneous binding effects through a non-cooperative behavior between cyclophosphamide hydrochloride and fluoxymesterone upon interaction with human serum albumin: multi-spectroscopic and molecular modeling approaches. Zohoorian-Abootorabi T; Sanee H; Iranfar H; Saberi MR; Chamani J Spectrochim Acta A Mol Biomol Spectrosc; 2012 Mar; 88():177-91. PubMed ID: 22217702 [TBL] [Abstract][Full Text] [Related]
74. Binding and Anticancer Properties of Plumbagin with Human Serum Albumin. Gou Y; Zhang Y; Qi J; Kong L; Zhou Z; Liang S; Yang F; Liang H Chem Biol Drug Des; 2015 Sep; 86(3):362-9. PubMed ID: 25534036 [TBL] [Abstract][Full Text] [Related]
75. Novel insights into the pleiotropic effects of human serum albumin in health and disease. Ha CE; Bhagavan NV Biochim Biophys Acta; 2013 Dec; 1830(12):5486-93. PubMed ID: 23602811 [TBL] [Abstract][Full Text] [Related]
76. Evaluation of enantioselective binding of antihistamines to human serum albumin by ACE. Martínez-Gómez MA; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ Electrophoresis; 2007 Aug; 28(15):2635-43. PubMed ID: 17605150 [TBL] [Abstract][Full Text] [Related]
77. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography. Zhu L; Yang F; Chen L; Meehan EJ; Huang M J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455 [TBL] [Abstract][Full Text] [Related]
78. Drugs modulate allosterically heme-Fe-recognition by human serum albumin and heme-fe-mediated reactivity. di Masi A; Leboffe L; Trezza V; Fanali G; Coletta M; Fasano M; Ascenzi P Curr Pharm Des; 2015; 21(14):1837-47. PubMed ID: 25732555 [TBL] [Abstract][Full Text] [Related]
79. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs. Bergamo A; Sava G Dalton Trans; 2011 Aug; 40(31):7817-23. PubMed ID: 21629963 [TBL] [Abstract][Full Text] [Related]
80. Biophysical studies on the interaction of platinum(II) complex containing antiviral drug ribavirin with human serum albumin. Shahabadi N; Hadidi S; Kalar ZM J Photochem Photobiol B; 2016 Jul; 160():376-82. PubMed ID: 27183492 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]